Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Gilead Sciences, Inc. shares valued at $1,795,287 were sold by Parsey Merdad on Sep 12 ’24. At $84.50 per share, Parsey Merdad sold 21,246 shares. The insider’s holdings dropped to 102,189 shares worth approximately $8.57 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Mercier Johanna sold 29,357 shares, netting a total of over 2,459,577 in proceeds. Following the sale of shares at $83.78 each, the insider now holds 78,127 shares.
Before that, MERDAD V PARSEY had added 21,246 shares to its account. In a trade valued at $1,795,287, the Officer bought Gilead Sciences, Inc. shares for $84.50 each.
As published in a research note from Raymond James on July 08, 2024, Gilead Sciences, Inc. [GILD] has been rated up from a Mkt perform to an Outperform and the price target has been revised to $93. Analysts at Maxim Group resumed the stock at ‘”a Buy”‘ outlook in a report released in early May. As of April 24, 2024, HSBC Securities has increased its “Reduce” rating to a “Hold” for GILD. Earlier on February 22, 2024, Truist downgraded its rating. Their new recommendation was “a Hold” for GILD stock which previously was a “a Buy”.
Analyzing GILD Stock Performance
During the last five days, there has been a surge of approximately 0.89%. Over the course of the year, Gilead Sciences, Inc. shares have jumped approximately 3.57%. Shares of the company reached a 52-week high of $87.86 on 01/19/24 and a 52-week low of $62.07 on 05/31/24. A 50-day SMA is recorded $76.49, while a 200-day SMA reached $73.56. Nevertheless, trading volume fell to 8.8 million shares from 9.2 million shares the previous day.
Support And Resistance Levels for Gilead Sciences, Inc. (GILD)
According to the 24-hour chart, there is a support level at 83.33, which, if violated, would cause prices to drop to 82.77. In the upper region, resistance lies at 84.56. The next price resistance is at 85.22. RSI (Relative Strength Index) is 75.33 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.41, which suggests the price will increase in the coming days. Percent R is at 13.85%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
